Sec Form 13G Filing - aaronson wayne filing for Tracon Pharmaceuticals Inc. (TCON) - 2024-03-19

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G/A

Under the Securities Exchange Act of 1934
(Amendment No. 2)

 

Tracon Pharmaceuticals, Inc.

(Name of Issuer)

 

Common Stock

(Title of Class of Securities)

 

89237H209

(CUSIP Number)

 

January 12, 2024

(Date of Event which requires filing of)

 

Check the appropriate box to designate the rule pursuant to which this Schedule this is filed.

 

 

¨

Rule 13d-1(b)

 

x

Rule 13d-1(c)

 

¨

Rule 13d-1(d)


 

  SCHEDULE 13G

 

CUSIP NO. 89237H209

Page 2 of 4

 

1

NAMES OF REPORTING PERSONS

 

WAYNE AARONSON

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ¨

(b) ¨

3

SEC USE ONLY

 

4

CITIZENSHIP

 

UNITED STATES



NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH:

5

SOLE VOTING POWER

 

716,925 shares

6

SHARED VOTING POWER

 

no shares

7

SOLE DISPOSITIVE POWER

 

716,925 shares

8

SHARED DISPOSITIVE POWER

 

no shares

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

716,925

10

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

N/A

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

2.3%

12

TYPE OF REPORTING PERSON

 

Individual


 

CUSIP NO. 89237H209

Page 3 of 4

 

Item 1.

 

 

 

 

(a)

Name of Issuer:

 

 

 

 

 

Tracon Pharmaceuticals, Inc.

 

 

 

 

(b)

Address of Issuer’s Principal Executive Offices:

 

 

 

 

 

4350 La Jolla Village Drive, Suite 800

 

 

San Diego, CA 92122

 

Item 2.

 

 

 

 

(a)

Name of Person Filing:

 

 

 

 

 

WAYNE AARONSON

 

 

 

 

(b)

Address of Principal Business Office or, if none, Residence

 

 

 

 

 

1011 Fresno Ave.

 

 

Berkeley, CA 94707

 

 

 

 

(c)

Citizenship:

 

 

 

 

 

United States

 

 

 

 

(d)

Title of Class of Securities

 

 

 

 

 

Common Stock

 

 

 

 

(e)

CUSIP Number

 

 

 

 

 

89237H209

 

Item 3.

 

N/A


 

CUSIP NO. 89237H209

Page 4 of 4

 

Item 4.

Ownership.

 

(a)716,945 shares of common stock held by Wayne Aaronson  

 

Roth IRA and no common stock held by Aaronson

 

Revocable Trust, Wayne Aaronson and Joy Chiyo Goto

 

co-trustees.

 

 

b)Percent of class: 2.3% based on 31,144,335 shares of Common Stock outstanding as of November 9, 2023 per Tracon's 10-K. 0 Number of shares as to which the person has:
 

(i)Sole power to vote or to direct the vote: 716,925 

 

(ii)Shared power to vote or to direct the vote: 0 

 

(iii)Sole power to dispose or to direct the disposition of: 716.925 

 

(iv)Shared power to dispose or to direct the disposition of: 0 

 

Item 5.

Ownership of Five Percent or Less of a Class.

 

XX 

 

Item 6.

Ownership of More than Five percent on Behalf of Another Person:

 

n/a

 

Item 8.

ID of Members of the Group:.

 

n/a

 

Item 9.

Notice of Dissolution of Group.

 

n/a

 

Item 10.

Certifications.

 

n/a After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete, and correct: 

 

March 15, 2023

 

By:

/s/Wayne Aaronson

 

 

Wayne Aaronson